Herborium Group, Inc.
HBRM · OTC
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 0.00% | 3,428.48% | -6.96% | 2.10% |
| EV / EBITDA | -7.48 | 5.42 | -11.33 | -19.60 |
| Quality | ||||
| ROIC | 9.96% | -0.88% | 9.19% | 10.33% |
| Gross Margin | 62.99% | 55.77% | 61.97% | 62.99% |
| Cash Conversion Ratio | 12.53 | 0.50 | -0.29 | -0.92 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.48% | 2.12% | 4.48% | 6.30% |
| Free Cash Flow Growth | 0.00% | 372.90% | -243.35% | 316.82% |
| Safety | ||||
| Net Debt / EBITDA | -3.68 | 5.36 | -3.95 | -3.71 |
| Interest Coverage | -6.97 | 0.00 | 0.00 | -6.97 |
| Efficiency | ||||
| Inventory Turnover | 32.42 | 30.94 | 19.59 | 64.83 |
| Cash Conversion Cycle | -135.58 | -65.65 | 11.35 | -202.98 |